EUVIMEDEUVIMED entdecken
EditorialKommentarOpen Access

Deciding where Trop-2 directed antibody drug conjugates work in non-small cell lung cancer: the not so straightforward road

Robert Hsu iD

Translational Cancer Research · 2025-02 · 14 (2) · 679-684

DOI: 10.21037/tcr-24-1870 ↗

Kurz gefasst

Editorial in der Zeitschrift Translational Cancer Research, 2025-02. Verfasst von Robert Hsu. Beteiligte Einrichtung: Division of Medical Oncology, Department of Medicine, University of Southern California Norris Comprehensive Cancer Center, Keck School of Medicine, …. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Lung cancerantibody drug conjugatesbiomarkers

Autor:innen und Institutionen

  • Division of Medical Oncology, Department of Medicine, University of Southern California Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

ORCID-Profile: Robert Hsu

Zitieren

APA

Hsu, R. (2025). Deciding where Trop-2 directed antibody drug conjugates work in non-small cell lung cancer: the not so straightforward road. Translational Cancer Research, 14(2), 679-684. https://doi.org/10.21037/tcr-24-1870

Vancouver

Hsu R. Deciding where Trop-2 directed antibody drug conjugates work in non-small cell lung cancer: the not so straightforward road. Translational Cancer Research. 2025;14(2):679-684. doi:10.21037/tcr-24-1870

BibTeX
@article{Hsu2025,
  author = {Hsu, Robert},
  title = {Deciding where Trop-2 directed antibody drug conjugates work in non-small cell lung cancer: the not so straightforward road},
  journal = {Translational Cancer Research},
  year = {2025},
  volume = {14},
  number = {2},
  pages = {679--684},
  doi = {10.21037/tcr-24-1870}
}
Kostenlos starten →